Are you Dr. Nagaraddi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4716 Ravendale Dr
Richardson, TX 75082Phone+1 972-860-9024Fax+1 972-525-8845
Summary
- Dr. Venkatesh Nagaraddi, MD is a board certified neurologist in Richardson, Texas. He is currently licensed to practice medicine in Texas, Iowa, and Tennessee. He is affiliated with Medical City Dallas, Texas Health Presbyterian Hospital Dallas, and Cook Children's Medical Center.
Education & Training
- Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2005 - 2006
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2002 - 2005
- AtlantiCare Regional Medical CenterInternship, Internal Medicine, 2001 - 2002
- Kasturba Medical College ManipalClass of 1998
Certifications & Licensure
- AZ State Medical License 2019 - 2026
- WA State Medical License 2019 - 2026
- UT State Medical License 2019 - 2026
- IA State Medical License 2024 - 2026
- IL State Medical License 2019 - 2026
- TN State Medical License 2024 - 2026
- MI State Medical License 2019 - 2026
- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsMulti-Biosignal Analysis for Epileptic Seizure Monitoring.Diana Cogan, Javad Birjandtalab, Mehrdad Nourani, Jay Harvey, Venkatesh Nagaraddi
International Journal of Neural Systems. 2017-02-01 - 7 citationsEfficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistanceR. Edward Hogan, Ilan Blatt, Balduin Lawson, Venkatesh Nagaraddi, Toufic Fakhoury
Epilepsy & Behavior. 2014-12-01 - 28 citationsOnce-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.Steve Chung, Toufic Fakhoury, R. Edward Hogan, Venkatesh Nagaraddi, Ilan Blatt
Epilepsia. 2014-07-01